WW 282 (Mefloquine 250 mg)
Pill imprint WW 282 has been identified as Mefloquine hydrochloride 250 mg.
Mefloquine is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial quinolines. Risk cannot be ruled out during pregnancy. Mefloquine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WW 282 (Mefloquine 250 mg)
- Imprint:
-
WW 282
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antimalarial quinolines
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- West-Ward Pharmaceutical Corporation
- National Drug Code (NDC):
- 00143-1282
- Inactive Ingredients:
- silicon dioxide colloidal
corn starch
crospovidone
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polysorbate 80
povidone k30
magnesium silicate
More resources
Mefloquine hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

